Global Biologic Therapeutics Industrial and Market studies 2016-2019
"Global
Biologic Therapeutics Market 2015-2019"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
About
biologic therapeutics
Biologic
therapeutics include virus, therapeutic serums, toxins, allergenic
products, antitoxin, blood components or derivatives, vaccines,
blood, and proteins (except any chemically synthesized polypeptide).
They also include analogous products, arsphenamine, or derivatives of
arsphenamine (or any other trivalent organic arsenic compound) for
the prevention, treatment, or cure of a disease. The differences
between the biologics and small molecules include the molecular
weight, structure, procedure of synthesis, and immunogenicity.
Biologics have a higher molecular weight and a complex molecular
structure. They are usually derived from living entities, which is
another important feature that differentiates it from small
molecules. Biologics are also vulnerable to extreme temperatures
(thermolabile) and light.
Covered
in this report
This
report covers the present scenario and the growth prospects of the
global biologic therapeutics market for the period 2015-2019. To
calculate the market size, the report considers revenue generated
through the sales protein therapeutics (monoclonal antibodies,
enzymes, and other protein therapeutics).
Other
protein therapeutics covers proteins such as cytokines, fusion
proteins, peptide antibiotics, peptide hormones, and blood factors.
The
report also presents the vendor landscape and a corresponding
detailed analysis of the top vendors in the market. The vendor
landscape section includes a market share analysis of the major
vendors along with the competitive performances of their product
portfolios. In addition, the report discusses the major drivers that
influence the growth of the market. It also outlines the challenges
faced by the vendors and the market at large, as well as the key
trends emerging in the market.
Technavio's
report, Global Biologic Therapeutics Market 2015-2019, has been
prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the Americas, APAC, and EMEA; it
also covers the landscape of the global biologic therapeutics market
and its growth prospects in the coming years. The report includes a
discussion of the key vendors operating in this market.
Key
regions
Americas
APAC
EMEA
Key
vendors
Amgen
F.
Hoffmann-La Roche
Novo
Nordisk
Sanofi
Other
prominent vendors
AbbVie
AstraZeneca
Bavarian
Nordic
Baxter
International
Beijing
Minhai Biotechnology
Bharat
Biotech
Bharat
Immunologicals and Biologicals
Bio
Med Pvt.
bioCSL
Biodel
Bristol-Myers
Squibb
Diamyd
Medical
DiaVacs
Dynavax
Technologies
Eli
Lilly
Generex
Biotechnology
Hualan
Biological Engineering
Imunoloski
Zavod
Indian
Immunologicals
Janssen
JN
International Medical
Kaketsuken
LG
Life Sciences
Macrogenics
MannKind
Merck
Mitsubishi
Tanabe Pharma
Nuron
Biotech
Osiris
Therapeutics
Pfizer
Protalix
Protein
Sciences
Serum
Institute of India
Shenzhen
Kangtai Biological Products
Sinovac
Biotech
Tolerion
Vacunas
Finlay
XOMA
Zydus
Cadila
Market
driver
Reimbursement
support for biologics
For
a full, detailed list, view our report
Market
challenge
High
cost of therapy
For
a full, detailed list, view our report
Market
trend
Emergence
of targeted and combination therapies
For
a full, detailed list, view our report
Key
questions answered in this report
What
will the market size be in 2019 and what will the growth rate be?
What
are the key market trends?
What
is driving this market?
Comments
Post a Comment